USC researchers have found older Americans know little about aducanumab (brand name Aduhelm™), despite the fact that an overwhelming majority of survey respondents said they were worried about Alzheimer’s disease.
Even when faced with larger structural risks, such as living in an area with high infection rates, people who avoid large gatherings and other risky behaviors are less likely to be diagnosed with COVID-19, say USC researchers.
A recent analysis of nearly 200,000 researchers – roughly the top 2% of the world’s scientists – has shown several USC Leonard Davis School of Gerontology faculty members to be among the most highly cited investigators on the planet.